PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level.

J Cancer · 2017 · PMC5665041 · PMID 29158797

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

a nonsignificant trendP = 0.072so close (0.05 < p ≤ 0.1)

Squamous cell carcinoma had a nonsignificant trend towards higher PD-L1 expression compared with adenocarcinoma (P = 0.072 for 10% cutoff, P = 0.138 for 50% cutoff).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.